At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Outcomes of an Adductor Canal Block Versus Liposomal Bupivacaine in Total Knee Arthroplasty Patients: A Randomized Prospective Study
In Brief
A Phase 4 clinical trial evaluating Liposomal Bupivacaine Peri-articular Injection and Adductor canal block for Total Knee Arthroplasty and Post-operative Pain Control. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This is a randomized prospective study of 60 patients undergoing total knee arthroplasty evaluating the clinical outcomes of liposomal bupivacaine periarticular injections (PAI) when compared to single shot adductor canal block using bupivacaine HCl.
Study Details
Timeline
Interventions
A 20mL solution of 266mg of liposomal bupivacaine (Exparel) was mixed with 40mL of normal saline, which was then infiltrated consistently in the posterior capsule, medial and lateral side of the arthrotomy, patella tendon, quadriceps tendon, quadriceps musculature, and subcutaneous soft tissue.
Anesthesiologist performs preoperative adductor canal block using 15mL of 0.5% Bupivacaine HCl